A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

NCT02065323 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Terminated due to budgetary considerations and length of development.

Conditions

Prostate Cancer

Interventions

DRUG: Standard ADT
DRUG: Dovitinib

Sponsor

Oscar Goodman, Jr.

Collaborators

[object Object]